S&P 500   3,971.34 (+1.79%)
DOW   31,888.42 (+2.00%)
QQQ   292.33 (+1.26%)
AAPL   142.43 (+3.52%)
MSFT   259.38 (+2.70%)
FB   195.12 (+0.82%)
GOOGL   2,224.70 (+2.14%)
AMZN   2,140.00 (-0.55%)
TSLA   668.12 (+0.64%)
NVDA   167.40 (+0.28%)
BABA   86.85 (+0.07%)
NIO   15.84 (-3.65%)
AMD   94.28 (+0.83%)
CGC   5.22 (-5.43%)
MU   69.24 (+0.49%)
T   20.79 (+1.91%)
GE   75.63 (+0.50%)
F   12.83 (+2.64%)
DIS   105.88 (+3.38%)
AMC   11.52 (-4.24%)
PFE   52.87 (+0.76%)
PYPL   80.85 (+0.38%)
NFLX   186.10 (-0.13%)
S&P 500   3,971.34 (+1.79%)
DOW   31,888.42 (+2.00%)
QQQ   292.33 (+1.26%)
AAPL   142.43 (+3.52%)
MSFT   259.38 (+2.70%)
FB   195.12 (+0.82%)
GOOGL   2,224.70 (+2.14%)
AMZN   2,140.00 (-0.55%)
TSLA   668.12 (+0.64%)
NVDA   167.40 (+0.28%)
BABA   86.85 (+0.07%)
NIO   15.84 (-3.65%)
AMD   94.28 (+0.83%)
CGC   5.22 (-5.43%)
MU   69.24 (+0.49%)
T   20.79 (+1.91%)
GE   75.63 (+0.50%)
F   12.83 (+2.64%)
DIS   105.88 (+3.38%)
AMC   11.52 (-4.24%)
PFE   52.87 (+0.76%)
PYPL   80.85 (+0.38%)
NFLX   186.10 (-0.13%)
S&P 500   3,971.34 (+1.79%)
DOW   31,888.42 (+2.00%)
QQQ   292.33 (+1.26%)
AAPL   142.43 (+3.52%)
MSFT   259.38 (+2.70%)
FB   195.12 (+0.82%)
GOOGL   2,224.70 (+2.14%)
AMZN   2,140.00 (-0.55%)
TSLA   668.12 (+0.64%)
NVDA   167.40 (+0.28%)
BABA   86.85 (+0.07%)
NIO   15.84 (-3.65%)
AMD   94.28 (+0.83%)
CGC   5.22 (-5.43%)
MU   69.24 (+0.49%)
T   20.79 (+1.91%)
GE   75.63 (+0.50%)
F   12.83 (+2.64%)
DIS   105.88 (+3.38%)
AMC   11.52 (-4.24%)
PFE   52.87 (+0.76%)
PYPL   80.85 (+0.38%)
NFLX   186.10 (-0.13%)
S&P 500   3,971.34 (+1.79%)
DOW   31,888.42 (+2.00%)
QQQ   292.33 (+1.26%)
AAPL   142.43 (+3.52%)
MSFT   259.38 (+2.70%)
FB   195.12 (+0.82%)
GOOGL   2,224.70 (+2.14%)
AMZN   2,140.00 (-0.55%)
TSLA   668.12 (+0.64%)
NVDA   167.40 (+0.28%)
BABA   86.85 (+0.07%)
NIO   15.84 (-3.65%)
AMD   94.28 (+0.83%)
CGC   5.22 (-5.43%)
MU   69.24 (+0.49%)
T   20.79 (+1.91%)
GE   75.63 (+0.50%)
F   12.83 (+2.64%)
DIS   105.88 (+3.38%)
AMC   11.52 (-4.24%)
PFE   52.87 (+0.76%)
PYPL   80.85 (+0.38%)
NFLX   186.10 (-0.13%)
NASDAQ:LPTX

Leap Therapeutics News Headlines

$1.13
-0.04 (-3.42%)
(As of 05/23/2022 03:17 PM ET)
Add
Compare
Today's Range
$1.13
$1.19
50-Day Range
$0.97
$1.91
52-Week Range
$0.92
$4.17
Volume
14,831 shs
Average Volume
1.21 million shs
Market Capitalization
$99.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.71
Get Leap Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LPTX and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Leap Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LPTX
News Sentiment

-0.46

0.30

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LPTX Articles
This Week

2

0

LPTX Articles
Average Week



Leap Therapeutics (NASDAQ:LPTX) News Headlines Today

SourceHeadline
marketbeat.com logoLeap Therapeutics (NASDAQ:LPTX) Releases Earnings Results, Beats Expectations By $0.01 EPS
marketbeat.com - May 16 at 7:53 AM
finance.yahoo.com logoWe're Keeping An Eye On Leap Therapeutics' (NASDAQ:LPTX) Cash Burn Rate
finance.yahoo.com - May 19 at 6:53 AM
finance.yahoo.com logoLeap Therapeutics Reports First Quarter 2022 Financial Results
finance.yahoo.com - May 13 at 5:47 PM
MarketBeat logo-$0.11 Earnings Per Share Expected for Leap Therapeutics, Inc. (NASDAQ:LPTX) This Quarter
americanbankingnews.com - May 9 at 5:16 AM
finance.yahoo.com logoShareholders in Leap Therapeutics (NASDAQ:LPTX) are in the red if they invested five years ago
finance.yahoo.com - April 9 at 10:14 AM
finance.yahoo.com logoLeap Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
finance.yahoo.com - March 19 at 1:25 AM
benzinga.com logoLeap Therapeutics's Return On Capital Employed Insights
benzinga.com - March 15 at 1:44 PM
benzinga.com logoLeap Therapeutics: Q4 Earnings Insights
benzinga.com - March 11 at 4:13 PM
finance.yahoo.com logoHow Many Leap Therapeutics, Inc. (NASDAQ:LPTX) Shares Do Institutions Own?
finance.yahoo.com - February 8 at 1:23 PM
seekingalpha.com logoLeap Therapeutics forms partnership to develop companion diagnostic for cancer patients
seekingalpha.com - January 31 at 11:48 AM
finance.yahoo.com logoLeap Therapeutics to Present at B. Riley Securities Oncology Investor Conference
finance.yahoo.com - January 24 at 10:10 AM
marketwatch.com logoLeap Therapeutics Shares Rise Premarket on Encouraging Study Data >LPTX
marketwatch.com - January 19 at 8:05 PM
finance.yahoo.com logoHedge Funds Are Crazy About LEAP THERAPEUTICS, INC. (LPTX)
finance.yahoo.com - January 12 at 5:21 PM
nasdaq.com logoCompanies Like Leap Therapeutics (NASDAQ:LPTX) Are In A Position To Invest In Growth
nasdaq.com - December 21 at 2:29 PM
finance.yahoo.com logoLeap Therapeutics (NASDAQ:LPTX) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - December 10 at 10:30 AM
finance.yahoo.com logoLeap Therapeutics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference
finance.yahoo.com - November 15 at 8:53 AM
finance.yahoo.com logoLeap Therapeutics Reports Third Quarter 2021 Financial Results
finance.yahoo.com - November 12 at 9:24 AM
finance.yahoo.com logoEarnings Preview: Leap Therapeutics, Inc. (LPTX) Q3 Earnings Expected to Decline
finance.yahoo.com - November 4 at 8:31 PM
finance.yahoo.com logoEarnings Preview: Leap Therapeutics, Inc. (LPTX) Q3 Earnings Expected to Decline
finance.yahoo.com - November 4 at 8:31 PM
finance.yahoo.com logoLeap Therapeutics (NASDAQ:LPTX) shareholders have earned a 63% return over the last year
finance.yahoo.com - October 11 at 1:31 PM
finance.yahoo.com logo3 Biotech Stocks That Surged in September
finance.yahoo.com - October 5 at 7:54 AM
benzinga.com logoLooking Into Leap Therapeutics's Return On Capital Employed
benzinga.com - October 1 at 1:02 PM
finance.yahoo.com logoLeap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - September 24 at 3:36 PM
finance.yahoo.com logoLeap Therapeutics Announces Pricing of $90 million of Common Stock and Pre-Funded Warrants
finance.yahoo.com - September 22 at 1:12 PM
benzinga.com logoWhy Leap Therapeutics Shares Are Trading Higher Today
benzinga.com - September 16 at 4:24 PM
finance.yahoo.com logoLeap Therapeutics to Present New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO 2021 Congress
finance.yahoo.com - September 13 at 7:52 AM
finance.yahoo.com logoLeap Therapeutics to Participate at Two Upcoming Virtual Investor Conferences
finance.yahoo.com - September 7 at 7:05 AM
finance.yahoo.com logoHere's What Leap Therapeutics, Inc.'s (NASDAQ:LPTX) Shareholder Ownership Structure Looks Like
finance.yahoo.com - August 12 at 11:15 AM
finance.yahoo.com logoAnalysts Estimate Leap Therapeutics, Inc. (LPTX) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - August 5 at 7:47 PM
finance.yahoo.com logoLeap Therapeutics to Present at the ESMO 2021 Virtual Congress
finance.yahoo.com - July 26 at 9:54 AM
finance.yahoo.com logoDown 19.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Leap Therapeutics, Inc. (LPTX)
finance.yahoo.com - July 19 at 1:12 PM
finance.yahoo.com logoLeap Therapeutics to Present at Ladenburg Thalmann 2021 Virtual Healthcare Conference
finance.yahoo.com - July 7 at 8:08 AM
finance.yahoo.com logoIs Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Invest In Growth?
finance.yahoo.com - June 7 at 1:54 PM
finance.yahoo.com logoLeap Therapeutics Reports First Quarter 2021 Financial Results
finance.yahoo.com - May 14 at 8:23 AM
finance.yahoo.com logoWill Leap Therapeutics, Inc. (LPTX) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com - May 6 at 5:28 PM
nasdaq.com logoWould Shareholders Who Purchased Leap Therapeutics' (NASDAQ:LPTX) Stock Three Years Be Happy With The Share price Today?
nasdaq.com - April 24 at 6:44 PM
finance.yahoo.com logoFlagship Biosciences and Leap Therapeutics Announce Partnership and Approach Using RNAscope and Image Analysis for Patient Enrollment
finance.yahoo.com - April 12 at 8:07 AM
finance.yahoo.com logoLeap Therapeutics Announces Completion of Enrollment for First-Line Patient Cohort in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Gastric or Gastroesophageal Junction Cancer
finance.yahoo.com - April 1 at 8:05 AM
finance.yahoo.com logoLeap Therapeutics Presents DKN-01 Clinical Data at the Society of Gynecologic Oncology 2021 Annual Meeting on Women's Cancer
finance.yahoo.com - March 22 at 9:50 AM
finance.yahoo.com logoIntroducing Leap Therapeutics (NASDAQ:LPTX), A Stock That Climbed 80% In The Last Year
finance.yahoo.com - March 19 at 11:41 AM
finance.yahoo.com logoWhat You Need To Know About Leap Therapeutics, Inc.'s (NASDAQ:LPTX) Investor Composition
finance.yahoo.com - January 19 at 5:42 PM
finance.yahoo.com logoLeap Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 9:47 AM
msn.com logoProduction On Fox Dramedy Pilot ‘The Big Leap’ Paused After Positive Covid-19 Tests
msn.com - December 18 at 5:50 PM
finance.yahoo.com logoIs LPTX A Good Stock To Buy Now?
finance.yahoo.com - December 12 at 1:00 AM
marketwatch.com logoGlobal Vertical Leap Training Equipment Market 2020 Key Dynamics, Recent and Future Demand, Trend, Analysis upto 2025
marketwatch.com - December 10 at 5:23 AM
cnbc.com logoMagic Leap CEO on the future of enterprise augmented reality
cnbc.com - December 3 at 3:21 PM
finance.yahoo.com logoLeap Therapeutics to Participate at Piper Sandler 32nd Annual Virtual Healthcare Conference
finance.yahoo.com - November 23 at 8:37 AM
finance.yahoo.com logoBrokers Are Upgrading Their Views On Leap Therapeutics, Inc. (NASDAQ:LPTX) With These New Forecasts
finance.yahoo.com - November 18 at 7:26 AM
seekingalpha.com logoLeap Therapeutics EPS beats by $0.04, beats on revenue
seekingalpha.com - November 12 at 8:13 AM
finance.yahoo.com logoLeap Therapeutics Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 12 at 8:13 AM
finance.yahoo.com logoLeap Therapeutics to Present at Stifel 2020 Healthcare Conference
finance.yahoo.com - November 10 at 7:38 AM
Get Leap Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LPTX and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.